Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease

BACKGROUND: Hypocalcaemia is increasingly recognized as a complication of denosumab use in Chronic Kidney Disease (CKD) patients with osteoporosis. Despite Therapeutic Goods Administration (TGA) notifications in 2013, we have subsequently encountered several cases of denosumab-induced hypocalcaemia,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalleh, Ryan, Basu, Gopal, Le Leu, Richard, Jesudason, Shilpanjali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241374/
https://www.ncbi.nlm.nih.gov/pubmed/30519493
http://dx.doi.org/10.1155/2018/7384763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241374/
https://www.ncbi.nlm.nih.gov/pubmed/30519493
http://dx.doi.org/10.1155/2018/7384763

Ejemplares similares